Efficacy Stem Cell in Treatment Autism
Not Applicable
- Conditions
- Autism.Childhood autism
- Registration Number
- IRCT201512315280N22
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
age range of =5 and =15 years
a definite diagnosis of ASD based on DSM
Exclusion Criteria
a long history of allergic reactions
seizures during the past six months
brain trauma
moderate to severe extrapyramidal symptoms and tardive dyskinesia
severe self-injury behavior
autoimmune diseases
severe hematologic and pulmonary disease (such as pneumonia, asthma, malignancy and immune deficiency)
severe focal or systemic infection (such as AIDS, hepatitis and syphilis)
kidney and liver problems
anemia and hemoglobin level less than 8 g/dL
bone marrow- associated diseases
receiving other treatments affecting the health of stem cell therapy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Autism. Timepoint: Baseline, 1, 3, 12 months. Method of measurement: GARSII test.;Autism. Timepoint: Baseline, 1, 3, 12 months. Method of measurement: CARS test.;Illness severity. Timepoint: Baseline, 1, 3, 12 months. Method of measurement: Clinical Global Impression (CGI).
- Secondary Outcome Measures
Name Time Method